- Open Access
HHV-8 encoded LANA-1 alters the higher organization of the cell nucleus
© Stuber et al; licensee BioMed Central Ltd. 2007
Received: 14 February 2007
Accepted: 13 April 2007
Published: 13 April 2007
The latency-associated nuclear antigen (LANA-1) of Human Herpes Virus 8 (HHV-8), alternatively called Kaposi Sarcoma Herpes Virus (KSHV) is constitutively expressed in all HHV-8 infected cells. LANA-1 accumulates in well-defined foci that co-localize with the viral episomes. We have previously shown that these foci are tightly associated with the borders of heterochromatin . We have also shown that exogenously expressed LANA-1 causes an extensive re-organization of Hoechst 33248 DNA staining patterns of the nuclei in non-HHV-8 infected cells . Here we show that this effect includes the release of the bulk of DNA from heterochromatic areas, in both human and mouse cells, without affecting the overall levels of heterochromatin associated histone H3 lysine 9 tri-methylation (3MK9H3). The release of DNA from the heterochromatic chromocenters in LANA-1 transfected mouse cells co-incides with the dispersion of the chromocenter associated methylcytosin binding protein 2 (MECP2). The localization of 3MK9H3 to the remnants of the chromocenters remains unaltered. Moreover, exogeneously expressed LANA-1 leads to the relocation of the chromocenters to the nuclear periphery, indicating extensive changes in the positioning of the chromosomal domains in the LANA-1 harboring interphase nucleus. Using a series of deletion mutants we have shown that the chromatin rearranging effects of LANA-1 require the presence of a short (57 amino acid) region that is located immediately upstream of the internal acidic repeats. This sequence lies within the previously mapped binding site to histone methyltransferase SUV39H1. We suggest that the highly concentrated LANA-1, anchored to the host genome in the nuclear foci of latently infected cells and replicated through each cell generation, may function as "epigenetic modifier". The induction of histone modification in adjacent host genes may lead to altered gene expression, thereby contributing to the viral oncogenesis.
Human herpesvirus virus 8 (HHV-8) is considered as the causative agent of Kaposi's sarcoma (KS) and is also associated with primary effusion lymphomas (PELs) and multicentric Castleman's disease (MCD). It is a gammaherpesvirus that shows sequence homology to Epstein-Barr virus (EBV) and herpesvirus saimiri (HVS) that are able to transform B (EBV) and T cells (HVS), respectively. Both viruses can cause malignant lymphomas . HHV-8 encodes a large number of proteins that show structural similarities with cellular proteins involved in cellular proliferation, cell cycle regulation and immune modulation . A human cyclin D homologue, vCYC, ORF72, a bcl-2 homologue, ORF16 , an IL-8-like G-protein coupled receptor, vGCRP, ORF74  and interferon regulatory factors, vIRFs, ORFK9, ORFK10.5  are among the genes that have been pirated by the virus.
The latency-associated nuclear antigen (LANA-1, LNA or LNA-1), encoded by ORF73, is one of few HHV-8 encoded proteins that is highly expressed in all latently infected tumor cells [7–9]. This suggests that LANA-1 plays a critical role in maintenance of latent HHV-8 infection. LANA-1 is a 222–234 kDa phosphoprotein with an acidic internal repeat domain flanked by a carboxy-terminal domain and an amino-terminal domain .
Constitutive expression of LANA-1 from its own promoter in transgenic mice induced splenic follicular hyperplasia due to an expansion of IgM+ IgD+ B cells and led to increased germinal center formation. LANA-1 expressing B-cell lesions could also progress to lymphomas .
LANA-1 acts as a transcriptional regulator. It has been shown to bind to p53 and to the retinoblastoma protein pRb. This leads to the inactivation of p53-dependent promoters and induction of E2F-dependent genes [11, 12]. Together with the cellular oncogene H-ras, LANA-1 transforms primary rat embryo fibroblasts . It can transactivate the promoter of the reverse transcriptase subunit of the human telomerase holoenzyme . Activation of telomerase is a critical step in cellular transformation . LANA-1 is also involved in transcriptional repression, however [16–18]. It can, moreover, interact with the mSin3/HDAC1 co-repressor complex . It has been also shown to interact with and inhibit the ATF4/CREB2 transcription factor that interacts with the basic transcription machinery . LANA-1 was also reported to bind two human chromosome-associated cellular proteins, MeCP2 and DEK .
RING3, a homology of the fsh (female sterile homeotic) gene product of Drosophila, interacts with LANA-1 . This results in the phosphorylation of LANA-1. We have shown by immunofluorescence that LANA-1 can re-locate RING3 into heterochromatin regions and that LANA-1 and RING3 co-localize in the nuclear bodies of BCBL-1 cells. Exogenously expressed LANA-1 increased the expression of RING3 .
LANA-1 is associates with cellular chromatin and stays on the chromosomes during cell division . It maintains the viral genomes during cell division by tethering the viral episomes to the chromosomes . It binds directly to replication origin recognition complexes (ORCs) that are primarily associated with the terminal repeat (TR) region of the HHV-8 genome . Binding of LANA-1 to TR confers transcriptional silencing, on the promoter of the neighbouring lytic gene K1 . LANA-1 is believed to play an important role in the suppression of lytic viral genes and maintenance of viral latency. The key lytic regulator protein, RTA activates the expression of several lytic viral genes by interacting with recombination signal sequence-binding protein Jkappa (RBP-Jkappa), a transcriptional repressor and the target of the Notch signaling pathway. Importantly, LANA-1 also suppresses RTA activity by its direct binding to RBP-Jkappa .
Distinct regions of the N-terminus of LANA-1 are responsible for nuclear targeting and binding to human chromosomes . The 1–22 N terminal residues of LANA-1 bind directly to an acidic patch on the core histone dimers H2A-H2B . LANA-1 shows a characteristic cellular distribution. The HHV-8 episomes and the associated LANA-1 protein accumulate in irregularly shaped bodies in the interphase nucleus, preferentially at the border of heterochromatin . It binds to human metaphase chromosomes in an apparently random fashion [21, 26]. Exogeneously expressed C terminal part of LANA-1 preferentially concentrates to paired dots at pericentromeric and peri-telomeric regions of a subset of mitotic chromosomes . A short 15 aa region in the C terminal part is responsible for the association with heterochromatin . This chromatin-binding domain is required for multiple LANA-1 functions, such as the ability to bind to and replicate viral episomes, to modulate transcription, and to interact with the members of Brd chromatin binding proteins Brd2/RING3 and Brd4s [30–32].
We have previously shown that exogenous expression of LANA-1 induces a major re-organization of DNA staining patterns. Here we show that this reorganization leads to the disappearance of normal heterochromatin pattern in both human and mouse cells. In order to further characterize the effect of LANA-1 on heterochromatin we have compared its distribution in HHV-8 carrying cells and in non-infected but LANA-1 transfected cells in relation to different heterochromatin markers.
Materials and methods
Cell culture conditions and cell lines
The cells were cultured at 37°C at 5% CO2 in Iscove's modified Dulbecco's cell culture medium supplemented with 10% heat-inactivated fetal bovine serum (FBS), 100 U/ml penicillin and 100 U/ml streptomycin. The cells were passaged and split 1:5 every fourth day. The cell cultures were regularly tested for the absence of mycoplasma infection by Hoechst 33258 staining. The cell lines used in this study were the following: the HHV-8 infected human body cavity lymphomas BC-1 and BCBL-1; human breast carcinoma MCF-7; human osteosarcoma cell line Saos-2, human cervical carcinoma HeLa; immortalized mouse fibroblasts NIH3T3 and mouse fibrosarcoma L (American Type Culture Collection (ATCC).
Transient transfection procedure
The human or mouse cells were grown on coverslips in six-well plates and transfected for 24–48 hours using a full-length LANA-1 cDNA inserted into a pcDNA1 vector or a LANA-1 deletion constructs . An empty vector or a pBabe EBNA-5 construct created by us was used for control transfections. Transfection of cells was made according to the manufacturer's instructions using FuGene6 (Roche).
The transfected cells (grown on coverslips) or body cavity lymphoma cell lines (cytospinned on to glass slides) were fixed in methanol: acetone (1:1) at -20°C for 20 min. The re-hydration of cells was done in PBS for 20 min at room temperature. The following antibodies were used in this study for immunofluorescence straining: human anti-LANA KS2 (antiserum, a gift from Attila Juhasz, the Dermatology Unit of Debrecen Medical School, Hungary), rabbit polyclonal anti-tri-methyl K9 histone H3 (A gift from Dr Prim Sing); rabbit polyclonal IgG anti-mouse MeCP2 (reacting with both human and murin MeCP2) (Upstate); FITC-conjugated swine anti-rabbit (DAKO); rhodamine-conjugated rabbit anti-human (DAKO); FITC-conjugated rabbit anti-human (DAKO) or Texas red-conjugated horse anti-mouse (Vector) were used as secondary antibodies. The different combinations of primary and secondary antibodies are specified in respective figures. The control transfection of pBabe-EBNA-5 was stained with a mouse monoclonal anti-EBNA-5 (JF186). Texas red-conjugated horse anti-mouse (Vector) was used as secondary antibody. The antibodies were diluted in blocking buffer (2% BSA, 0.2% Tween-20, 10% glycerol, 0.05% NaN3 in PBS). The primary antibodies were incubated in a humid chamber at room temperature for one hour followed by three washes with PBS. Incubation with the secondary antibodies was done for one hour in humid chamber at room temperature. Double staining between LANA-1 and the different chromatin-associated proteins were done as follows: rabbit anti-tri-methyl K9 H3 or rabbit anti-MeCP2, FITC-conjugated swine anti-rabbit, normal rabbit, human anti LANA-1 and at last rhodamine conjugated rabbit anti-human. DEK double staining: mouse anti-DEK, Texas red conjugated horse anti-mouse, normal mouse, human anti-LANA1 and FITC conjugated rabbit anti-human. The DNA was stained with Hoechst 33258. Each incubation step was followed by three washes in PBS.
The images were captured with one of the following systems: Leitz DM RB wide field fluorescence microscope equipped with a Hamamatsu dual mode cooled CCD camera C4880 where the images were recorded and analysed on a Pentium PC computer equipped with an AFG VISIONplus-AT frame grabber board using Hipic 4.0.4 (Hamamatsu), Image-Pro Plus (Media Cybergenetics). Digital images were assembled using Adobe PHOTOSHOP software. Alternatively a Zeiss Axiophot microscope was used to reconstitute images from a series of optical sections that were de-blurred by removing the out-of-focus blur using a nearest neighbor de-convolution algorithm developed by us. On this system the images were captured with a PXL cooled camera (Photometrics, Munich, Germany) and analyzed using our own image capture and analysis programs developed on ISee graphical programming language running under Mandrake LINUX OS on a Pentium PC computer . Confocal images and very large field mosaics were captured using our custom built dual mode Ultraview (combined RS and LCI) system (Perkin Elmer) using imaging automations QuantCapture 4.0 and QuantCount 3 that we have developed using OpenLab Automator programming environment (Improvision). 3D reconstitution was carried out using Volocity (Improvision) or ImageJ programs.
Effect of exogeneously expressed LANA-1 on nuclear structures of human cells
Effect of exogenously expressed LANA-1 on nuclear structures of mouse cells
Mapping the LANA-1 region required for the chromatin effects using deletion mutants
HHV8 carrying cells can harbor up to a few dozen viral episomes that localize in discrete nuclear compartments delineated by LANA-1. LANA-1 as multifunctional virally encoded protein, involved in the maintenance of the viral episomes, regulation of viral latency, transcriptional regulation of viral and cellular genes and impairment of cell cycle checkpoints . Several of these functions may play a role in the HHV8 induced malignant transformation of Kaposi sarcoma and body cavity lymphoma cells. In this paper we have presented additional evidence that LANA-1 may also have fundamental effects on the organization of the interphase nucleus. They are most clearly seen in mouse cell nuclei where the pericentromeric heterochromatin forms easily recognizable chromocenters. The bulk of the heterochromatin associated DNA is released from the chromocenters without affecting their 3MK9H3 content. This suggests indirectly, that a large part of the DNA that is associated with the chromocenters contains nucleosomes that are not trimethylated on the 9th lysine of histone H3, a modification that is considered to be the hallmark of heterochromatin organization. Our data suggest that chromatin with 3MK9H3 modified nucleosomes is interspersed with nonmodified nucleosomes inside the heterochromatic areas and that LANA-1 has a strong dispersing effect on this type of chromatin. It is likely that this chromatin fraction is heavily methylated on CpG sites, indicated by the profound effect on the distribution of MECP2 protein. The release of MECP2 from heterochromatin is probably not due to a direct stable interaction with LANA-1 because the two proteins showed no co-localization in either the transfected or in the virus carrying cells. LANA-1 binds MECP2 in vitro and in co-immunoprecipitation experiments. The presented morphological distribution data suggest that this interaction in vivo may occur outside of the LANA bodies in the virus infected cells and the complex may have a short half life.
3MK9H3 labelled chromocenter remnants may also function as markers of the centromeric side of interphase chromosome domains in mouse cells. The relocation of these foci from the interior of the nucleus to the nuclear periphery indicates major reshuffling of individual chromosomes in the LANA-1 containing interphase nuclei. The mechanism that determines the position of the different chromosomal domains in the nucleus is debated. Several theories were proposed to explain the relative localization and movements of chromosomal domains within the interphase nucleus. They can be referred to as the gene density theory, chromosome size theory and the mitotic pre-set theory (position within the metaphase plate), as reviewed by [37, 38]. The relative position and mobility of individual chromosomes have an obvious bearing on the occurence of chromosomal translocations. Our findings raise the possibility that LANA-1 may contribute to the development of the numerous chromosome rearrangements and translocations, seen in HHV8 carrying body cavity lymphoma lines .
The analysis of deletion mutants has revealed an area, corresponding to the SUV39H1 binding site, is required for the LANA-1 induced chromatin effects. SUV39H histone methyltransferases govern histone H3 lysine 9 (H3–K9) methylation at the pericentric heterochromatin and induces a specialized histone methylation pattern that differs from the broad H3–K9 methylation present at other chromosomal regions. Trimethyl H3K9 is a marker of constitutive heterochromatin. Mouse chromocenters are clusters of late-replicating pericentric heterochromatin that contains heterochromatin associated protein 1 (HP1) bound to 3M-H3K9. It has been suggested that H3–K9 methylation may function as a major "switch" for the functional organization of chromosomal subdomains. The viability of SUV39H-deficient mice is severely impaired suggesting that the SUV39H HMTases are important epigenetic regulators for mammalian development . The chromosomal instability of SUV39H-deficient mice is associated with an increased tumor risk and perturbed chromosome interactions during male meiosis. Mouse cells, deficient for both SUV39H1 and H2 show very similar Hoechst 33258 staining patterns to the ones that we have described in the present paper. Pericentromeric H3–K9 tri-methylation is believed to play an important role in protecting genome stability. Our data suggest that LANA-1 does not alter the overall level of H3–K9 tri-methylation but releases DNA from heterochromatic areas. Considering that the viral episomes are anchored to the heterochromatin borderlines, the virus may need a molecular mechanism to prevent overall heterochromatization, as seen in the positional effect variegation described in Drosophila and regulated by the fly variant of SUV39 (Su(var)3–9 Suppressor of variegation 3–9). LANA-1 may play a crucial role in the regulation of histone modifications of the viral genes and those cellular genes that are in close proximity to the viral episome. Indeed, LANA-1 can mediate the inactivation of lytic cycle associated genes in the neighborhood of the terminal repeats through local interaction with SUV39H1. More generally, LANA-1 may have a complex effect on the epigenetic modifications of the viral and host genome. It interacts with a set of proteins that influence histone modifications responsible for heterochromatin formation. Its interaction with retinoblastoma protein (RB1) may also have a direct effect on heterochromatin formation. Gonzalo et al. (2005) showed that members of the RB family are directly involved of in heterochromatin formation, through their interaction with HMTs, independently of the interaction with E2F. LANA-1 also binds to the de novo DNA methyltransferases DNMT3A  that in turn bind to another euchromatic histone methyltransferase SETDB1/ESET. The latter can also trimethylate H3–K9 .
In the view of the massive effect of exogenously expressed LANA-1 on chromatin structure in transfected cells it is reasonable to assume that endogenous LANA in virus carrying cells has a similar effect on the neighboring chromatin of LANA bodies that contain comparable quantities of LANA in well circumscribed areas.
The focal concentration of LANA-1 in latently infected cells with fixed anchorage to certain chromosomal sites raises the possibility for an a new paradigm of the "epigenetic modifier" that may generate locally altered chromatin states in regions of the host genome, affected at random. Once established it may be propagated over series of cell divisions. The altered epigenetic state may affect target genes involved in growth control. Through this mechanism the anchored LANA bodies may directly participate in the virus induced cellular transformation. This scenario implies the experimentally testable prediction that the altered expression of some cellular genes at the LANA body anchorage sites may contribute to the generation of HHV-8 harboring tumors such as Kaposi sarcomas and body cavity lymphomas. Systematic cloning effort using chromatin immunoprecipitation (Chip) material should enrich for these sequences. To identify the important target sequences, individual clones from one anti-LANA Chip cloning experiment should be arrayed. (Obviously clones with viral DNA inserts should be excluded). This array should be repeatedly probed with labeled Chip material from a number of HHV-8 bearing tumors from different individuals (Chip-on-chip). Clones that consistently light up with probes from a number of different tumors may be good candidate targets for the "epigenetic modifier" effect of the anchored viral episome.
This work was supported by Cancerfonden, the Swedish Research Council, the Center for Integrative Recognition in the Immune System (IRIS) and the Karolinska Institutet (Sweden) as well as the Cancer Research Institute/Cancer Foundation (USA).
- Szekely L, Kiss C, Mattsson K, Kashuba E, Pokrovskaja K, Juhasz A, Holmvall P, Klein G: Human herpesvirus-8-encoded LNA-1 accumulates in heterochromatin-associated nuclear bodies. J Gen Virol. 1999, 80 (Pt 11): 2889-2900.View ArticlePubMedGoogle Scholar
- Mattsson K, Kiss C, Platt GM, Simpson GR, Kashuba E, Klein G, Schulz TF, Szekely L: Latent nuclear antigen of Kaposi's sarcoma herpesvirus/human herpesvirus-8 induces and relocates RING3 to nuclear heterochromatin regions. J Gen Virol. 2002, 83: 179-188.View ArticlePubMedGoogle Scholar
- Neipel F, Albrecht JC, Fleckenstein B: Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: determinants of its pathogenicity?. J Virol. 1997, 71: 4187-4192.PubMed CentralPubMedGoogle Scholar
- Moore PS, Boshoff C, Weiss RA, Chang Y: Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science. 1996, 274: 1739-1744. 10.1126/science.274.5293.1739View ArticlePubMedGoogle Scholar
- Cheng EH, Nicholas J, Bellows DS, Hayward GS, Guo HG, Reitz MS, Hardwick JM: A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. Proc Natl Acad Sci USA. 1997, 94: 690-694. 10.1073/pnas.94.2.690PubMed CentralView ArticlePubMedGoogle Scholar
- Cesarman E, Nador RG, Bai F, Bohenzky RA, Russo JJ, Moore PS, Chang Y, Knowles DM: Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma. J Virol. 1996, 70: 8218-8223.PubMed CentralPubMedGoogle Scholar
- Kedes DH, Lagunoff M, Renne R, Ganem D: Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus. J Clin Invest. 1997, 100: 2606-2610.PubMed CentralView ArticlePubMedGoogle Scholar
- Kellam P, Boshoff C, Whitby D, Matthews S, Weiss RA, Talbot SJ: Identification of a major latent nuclear antigen, LNA-1, in the human herpesvirus 8 genome. J Hum Virol. 1997, 1: 19-29.PubMedGoogle Scholar
- Rainbow L, Platt GM, Simpson GR, Sarid R, Gao SJ, Stoiber H, Herrington CS, Moore PS, Schulz TF: The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen. J Virol. 1997, 71: 5915-5921.PubMed CentralPubMedGoogle Scholar
- Fakhari FD, Jeong JH, Kanan Y, Dittmer DP: The latency-associated nuclear antigen of Kaposi sarcoma-associated herpesvirus induces B cell hyperplasia and lymphoma. J Clin Invest. 2006, 116: 735-742. 10.1172/JCI26190PubMed CentralView ArticlePubMedGoogle Scholar
- Friborg J, Kong W, Hottiger MO, Nabel GJ: p53 inhibition by the LANA protein of KSHV protects against cell death. Nature. 1999, 402: 889-894.PubMedGoogle Scholar
- Komatsu T, Ballestas ME, Barbera AJ, Kaye KM: The KSHV latency-associated nuclear antigen: a multifunctional protein. Front Biosci. 2002, 7: d726-730.View ArticlePubMedGoogle Scholar
- Radkov SA, Kellam P, Boshoff C: The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells. Nat Med. 2000, 6: 1121-1127. 10.1038/80459View ArticlePubMedGoogle Scholar
- Knight JS, Cotter MA, Robertson ES: The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus transactivates the telomerase reverse transcriptase promoter. J Biol Chem. 2001, 276: 22971-22978. 10.1074/jbc.M101890200View ArticlePubMedGoogle Scholar
- Jeong JH, Orvis J, Kim JW, McMurtrey CP, Renne R, Dittmer DP: Regulation and autoregulation of the promoter for the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J Biol Chem. 2004, 279: 16822-16831. 10.1074/jbc.M312801200View ArticlePubMedGoogle Scholar
- Garber AC, Hu J, Renne R: Latency-associated nuclear antigen (LANA) cooperatively binds to two sites within the terminal repeat, and both sites contribute to the ability of LANA to suppress transcription and to facilitate DNA replication. J Biol Chem. 2002, 277: 27401-27411. 10.1074/jbc.M203489200View ArticlePubMedGoogle Scholar
- Krithivas A, Young DB, Liao G, Greene D, Hayward SD: Human herpesvirus 8 LANA interacts with proteins of the mSin3 corepressor complex and negatively regulates Epstein-Barr virus gene expression in dually infected PEL cells. J Virol. 2000, 74: 9637-9645. 10.1128/JVI.74.20.9637-9645.2000PubMed CentralView ArticlePubMedGoogle Scholar
- Schwam DR, Luciano RL, Mahajan SS, Wong L, Wilson AC: Carboxy terminus of human herpesvirus 8 latency-associated nuclear antigen mediates dimerization, transcriptional repression, and targeting to nuclear bodies. J Virol. 2000, 74: 8532-8540. 10.1128/JVI.74.18.8532-8540.2000PubMed CentralView ArticlePubMedGoogle Scholar
- Lim C, Sohn H, Gwack Y, Choe J: Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) binds ATF4/CREB2 and inhibits its transcriptional activation activity. J Gen Virol. 2000, 81: 2645-2652.View ArticlePubMedGoogle Scholar
- Platt GM, Simpson GR, Mittnacht S, Schulz TF: Latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts with RING3, a homolog of the Drosophila female sterile homeotic (fsh) gene. J Virol. 1999, 73: 9789-9795.PubMed CentralPubMedGoogle Scholar
- Szekely L, Chen F, Teramoto N, Ehlin-Henriksson B, Pokrovskaja K, Szeles A, Manneborg-Sandlund A, Lowbeer M, Lennette ET, Klein G: Restricted expression of Epstein-Barr virus (EBV)-encoded, growth transformation-associated antigens in an EBV- and human herpesvirus type 8-carrying body cavity lymphoma line. J Gen Virol. 1998, 79 (Pt 6): 1445-1452.View ArticlePubMedGoogle Scholar
- Ballestas ME, Chatis PA, Kaye KM: Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science. 1999, 284: 641-644. 10.1126/science.284.5414.641View ArticlePubMedGoogle Scholar
- Verma SC, Lan K, Choudhuri T, Robertson ES: Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen modulates K1 expression through its cis-acting elements within the terminal repeats. J Virol. 2006, 80: 3445-3458. 10.1128/JVI.80.7.3445-3458.2006PubMed CentralView ArticlePubMedGoogle Scholar
- Verma SC, Choudhuri T, Kaul R, Robertson ES: Latency-associated nuclear antigen (LANA) of Kaposi's sarcoma-associated herpesvirus interacts with origin recognition complexes at the LANA binding sequence within the terminal repeats. J Virol. 2006, 80: 2243-2256. 10.1128/JVI.80.5.2243-2256.2006PubMed CentralView ArticlePubMedGoogle Scholar
- Lan K, Kuppers DA, Verma SC, Sharma N, Murakami M, Robertson ES: Induction of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen by the lytic transactivator RTA: a novel mechanism for establishment of latency. J Virol. 2005, 79: 7453-7465. 10.1128/JVI.79.12.7453-7465.2005PubMed CentralView ArticlePubMedGoogle Scholar
- Piolot T, Tramier M, Coppey M, Nicolas JC, Marechal V: Close but distinct regions of human herpesvirus 8 latency-associated nuclear antigen 1 are responsible for nuclear targeting and binding to human mitotic chromosomes. J Virol. 2001, 75: 3948-3959. 10.1128/JVI.75.8.3948-3959.2001PubMed CentralView ArticlePubMedGoogle Scholar
- Barbera AJ, Chodaparambil JV, Kelley-Clarke B, Luger K, Kaye KM: Kaposi's sarcoma-associated herpesvirus LANA hitches a ride on the chromosome. Cell Cycle. 2006, 5: 1048-1052.View ArticlePubMedGoogle Scholar
- Kelley-Clarke B, Ballestas ME, Komatsu T, Kaye KM: Kaposi's sarcoma herpesvirus C-terminal LANA concentrates at pericentromeric and peri-telomeric regions of a subset of mitotic chromosomes. Virology. 2006,Google Scholar
- Viejo-Borbolla A, Kati E, Sheldon JA, Nathan K, Mattsson K, Szekely L, Schulz TF: A Domain in the C-terminal region of latency-associated nuclear antigen 1 of Kaposi's sarcoma-associated Herpesvirus affects transcriptional activation and binding to nuclear heterochromatin. J Virol. 2003, 77: 7093-7100. 10.1128/JVI.77.12.7093-7100.2003PubMed CentralView ArticlePubMedGoogle Scholar
- You J, Srinivasan V, Denis GV, Harrington WJ, Ballestas ME, Kaye KM, Howley PM: Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomes. J Virol. 2006, 80: 8909-8919. 10.1128/JVI.00502-06PubMed CentralView ArticlePubMedGoogle Scholar
- Viejo-Borbolla A, Ottinger M, Bruning E, Burger A, Konig R, Kati E, Sheldon JA, Schulz TF: Brd2/RING3 interacts with a chromatin-binding domain in the Kaposi's Sarcoma-associated herpesvirus latency-associated nuclear antigen 1 (LANA-1) that is required for multiple functions of LANA-1. J Virol. 2005, 79: 13618-13629. 10.1128/JVI.79.21.13618-13629.2005PubMed CentralView ArticlePubMedGoogle Scholar
- Ottinger M, Christalla T, Nathan K, Brinkmann MM, Viejo-Borbolla A, Schulz TF: Kaposi's sarcoma-associated herpesvirus LANA-1 interacts with the short variant of BRD4 and releases cells from a BRD4- and BRD2/RING3-induced G1 cell cycle arrest. J Virol. 2006, 80: 10772-10786. 10.1128/JVI.00804-06PubMed CentralView ArticlePubMedGoogle Scholar
- Finke J, Rowe M, Kallin B, Ernberg I, Rosen A, Dillner J, Klein G: Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines. J Virol. 1987, 61: 3870-3878.PubMed CentralPubMedGoogle Scholar
- Holmvall P, Szekely L: Computer programs that allow fast acquisition, visualization and overlap quantitation of fluorescent 3D microscopic objects using nearest neighbor deconvolution algorithm. Appl Immunochem and Molecular Morph. 1999, 7: 226-236. 10.1097/00022744-199909000-00009.View ArticleGoogle Scholar
- Sakakibara S, Ueda K, Nishimura K, Do E, Ohsaki E, Okuno T, Yamanishi K: Accumulation of heterochromatin components on the terminal repeat sequence of Kaposi's sarcoma-associated herpesvirus mediated by the latency-associated nuclear antigen. J Virol. 2004, 78: 7299-7310. 10.1128/JVI.78.14.7299-7310.2004PubMed CentralView ArticlePubMedGoogle Scholar
- Verma SC, Lan K, Robertson E: Structure and function of latency-associated nuclear antigen. Curr Top Microbiol Immunol. 2007, 312: 101-136.PubMed CentralPubMedGoogle Scholar
- Foster HA, Bridger JM: The genome and the nucleus: a marriage made by evolution. Genome organisation and nuclear architecture. Chromosoma. 2005, 114: 212-229. 10.1007/s00412-005-0016-6View ArticlePubMedGoogle Scholar
- Cremer M, Zinner R, Stein S, Albiez H, Wagler B, Cremer C, Cremer T: Three dimensional analysis of histone methylation patterns in normal and tumor cell nuclei. Eur J Histochem. 2004, 48: 15-28.PubMedGoogle Scholar
- Peters AH, O'Carroll D, Scherthan H, Mechtler K, Sauer S, Schofer C, Weipoltshammer K, Pagani M, Lachner M, Kohlmaier A: Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability. Cell. 2001, 107: 323-337. 10.1016/S0092-8674(01)00542-6View ArticlePubMedGoogle Scholar
- Shamay M, Krithivas A, Zhang J, Hayward SD: Recruitment of the de novo DNA methyltransferase Dnmt3a by Kaposi's sarcoma-associated herpesvirus LANA. Proc Natl Acad Sci USA. 2006, 103: 14554-14559. 10.1073/pnas.0604469103PubMed CentralView ArticlePubMedGoogle Scholar
- Li H, Rauch T, Chen ZX, Szabo PE, Riggs AD, Pfeifer GP: The histone methyltransferase SETDB1 and the DNA methyltransferase DNMT3A interact directly and localize to promoters silenced in cancer cells. J Biol Chem. 2006, 281: 19489-19500. 10.1074/jbc.M513249200View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.